Problems of stopping trials early.
Departments of Clinical Epidemiology and Biostatistics and Medicine, McMaster University, Hamilton, Ontario, Canada L8N 3Z5. guyatt@mcmaster.ca
Gordon H
GH
Guyatt
Matthias
M
Briel
Paul
P
Glasziou
Dirk
D
Bassler
Victor M
VM
Montori
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D026661:Clinical Trials Data Monitoring Committees; D016638:Critical Illness; D003657:Decision Making; D023381:Endpoint Determination; D032984:Ethics, Research; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000517:prevention & control; D011486:Protein C / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D018805:Sepsis / Q000188:drug therapy; D013514:Surgical Procedures, Operative / Q000009:adverse effects; D013997:Time Factors; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D007328:Insulin; D011486:Protein C